Amgad E. Agroudy-El

Al Mansurah, DK, Egypt

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Characteristics of patients with Banff borderline changes in renal allograft biopsies.

Characteristics of patients with Banff borderline changes in renal allograft biopsies.

Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
Published: April 01, 2010

A single-center experience of renal transplantation in elderly patients.

A single-center experience of renal transplantation in elderly patients.

Journal: Annals of transplantation
Published: December 17, 2009

Pretransplant detection of anti-endothelial cell antibodies could predict renal allograft outcome.

Pretransplant detection of anti-endothelial cell antibodies could predict renal allograft outcome.

Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
Published: September 01, 2009

Cyclosporine therapeutic monitoring with Cmax in kidney transplant recipients: does it fit for all populations?

Cyclosporine therapeutic monitoring with Cmax in kidney transplant recipients: does it fit for all populations?

Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
Published: April 03, 2009

The health of elderly living kidney donors after donation.

The health of elderly living kidney donors after donation.

Journal: Annals of transplantation
Published: November 27, 2008

Safe conversion of mycophenolate mofetil to azathioprine in kidney transplant recipients with sirolimus-based immunosuppression.

Safe conversion of mycophenolate mofetil to azathioprine in kidney transplant recipients with sirolimus-based immunosuppression.

Journal: Nephrology (Carlton, Vic.)
Published: November 20, 2008

Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.

Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.

Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
Published: October 29, 2008

Characteristics of recipients whose kidney allograft has functioned for more than 20 years.

Characteristics of recipients whose kidney allograft has functioned for more than 20 years.

Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
Published: September 26, 2008

Soluble Fas: a useful marker of inflammation and cardiovascular diseases in uremic patients.

Soluble Fas: a useful marker of inflammation and cardiovascular diseases in uremic patients.

Journal: Clinical and experimental nephrology
Published: August 08, 2008

Cyclosporine therapeutic monitoring with C(MAX) in kidney transplant recipients: racial considerations.

Cyclosporine therapeutic monitoring with C(MAX) in kidney transplant recipients: racial considerations.

Journal: Clinical and experimental nephrology
Published: June 26, 2008

Long-term graft outcome in patients with chronic allograft dysfunction after immunosuppression modifications.

Long-term graft outcome in patients with chronic allograft dysfunction after immunosuppression modifications.

Journal: Annals of transplantation
Published: May 09, 2008

Long-term graft outcome in patients with chronic allograft nephropathy after immunosuppression modifications.

Long-term graft outcome in patients with chronic allograft nephropathy after immunosuppression modifications.

Journal: Clinical and experimental nephrology
Published: May 08, 2008
Showing 1-12 of 13

Last Updated: 09/26/2026